Aneeka Chatterjee, Sanket Koul

All stories by Aneeka Chatterjee, Sanket Koul

Dr Reddy's profit down 14% on low Lenalidomide US sales
Rediff.com1 days ago

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y)...

NEET-PG Cutoff Cut Sparks Merit Debate
Rediff.com1 days ago

'To fill these seats, eligibility is being diluted. We are compromising merit and...

Cheers! Kingfisher rolls out Smooth for beer aficionados
Rediff.com7 days ago

The new beer's rollout has begun in Rajasthan. Under a phased expansion strategy,...

Women Power India's Retail Push
Rediff.com5 Jan 2026

'It's harder to attract women initially, but once they come in, retention is...

Govt Bans Sale Of Oral Nimesulide
Rediff.com2 Jan 2026

The Union health ministry has banned the manufacture, sale and distribution of all oral...

Centre Proposes Stricter Cough Syrup Rules
Rediff.com1 Jan 2026

Following the death of 22 children due to consumption of contaminated cough syrups in...

Why non- NCR developers are flocking to Gurugram
Rediff.com30 Dec 2025

Gurugram, already established as the corporate hub of Delhi-NCR, is increasingly...

GIFT City Raises A Glass to Global Business
Rediff.com24 Dec 2025

The latest move removes one of the key friction points for visitors, temporary liquor...

Weightloss Drugs Hit 1,000 Crore Mark
Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and...

Malaysia's IHH plans India expansion after Fortis open offer
Rediff.com16 Dec 2025

After completion of its mandatory tender offer in Fortis Healthcare and Fortis Malar...

Biocon launches diabetes & obesity drugs in Netherlands
Rediff.com16 Dec 2025

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of...

One-Regulator Education Bill Sent To Panel
Rediff.com16 Dec 2025

'It interferes in administrative matters of institutions, robbing them of their...

'14+ Anti-Obesity Drugs In The Pipeline'
Rediff.com13 Dec 2025

The semaglutide patent expiry next year could unleash a wave of generic versions from...

20% Shopping Centres Are Ghost Malls
Rediff.com12 Dec 2025

Ghost malls have a vacancy rate of over 50 per cent.

Indian Student Numbers Surge at UCL
Rediff.com10 Dec 2025

University College London has recorded a 19 per cent and 26 per cent rise in...

Pan masala cess to boost public health, security
Rediff.com8 Dec 2025

Experts said that earmarking of funds for public health at par with national security...

IIT Students Get 90 Lakh To 3 Cr Offers!
Rediff.com4 Dec 2025

Several IITs have been pushing for a diversification of job profiles as roles move...

PMJAY for 70+ covered 700K treatments in one year
Rediff.com2 Dec 2025

The government aims to cover around 60 million people in the age category, irrespective...

Affordable homes no longer attractive to investors
Rediff.com27 Nov 2025

Affordable homes, priced under Rs 40 lakh per unit, may not be attractive anymore, not...

JLR Boosts India Tech Hub With 106-Crore Lease
Rediff.com18 Nov 2025

The deal includes a security deposit of 10.10 crore and features an unusually steep 15...